These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31444530)

  • 1. What has zinc transporter 8 autoimmunity taught us about type 1 diabetes?
    Williams CL; Long AE
    Diabetologia; 2019 Nov; 62(11):1969-1976. PubMed ID: 31444530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.
    Achenbach P; Lampasona V; Landherr U; Koczwara K; Krause S; Grallert H; Winkler C; Pflüger M; Illig T; Bonifacio E; Ziegler AG
    Diabetologia; 2009 Sep; 52(9):1881-8. PubMed ID: 19590848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
    Wenzlau JM; Juhl K; Yu L; Moua O; Sarkar SA; Gottlieb P; Rewers M; Eisenbarth GS; Jensen J; Davidson HW; Hutton JC
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17040-5. PubMed ID: 17942684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
    Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
    Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus.
    Yi B; Huang G; Zhou Z
    J Diabetes Investig; 2016 Jul; 7(4):459-65. PubMed ID: 27181765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases.
    Howson JM; Krause S; Stevens H; Smyth DJ; Wenzlau JM; Bonifacio E; Hutton J; Ziegler AG; Todd JA; Achenbach P
    Diabetologia; 2012 Jul; 55(7):1978-84. PubMed ID: 22526605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
    Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
    Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes?
    Urrutia I; Martínez R; Rica I; Martínez de LaPiscina I; García-Castaño A; Aguayo A; Calvo B; Castaño L;
    PLoS One; 2019; 14(7):e0220634. PubMed ID: 31365591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.
    Skärstrand H; Krupinska E; Haataja TJ; Vaziri-Sani F; Lagerstedt JO; Lernmark Å
    Clin Exp Immunol; 2015 Feb; 179(2):220-9. PubMed ID: 25178386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet Autoantibodies.
    Lampasona V; Liberati D
    Curr Diab Rep; 2016 Jun; 16(6):53. PubMed ID: 27112957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes.
    Andersen MK; Härkönen T; Forsblom C; Groop PH; Knip M; Tuomi T
    Autoimmunity; 2013 Jun; 46(4):251-8. PubMed ID: 23194113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZnT8 and type 1 diabetes.
    Kawasaki E
    Endocr J; 2012; 59(7):531-7. PubMed ID: 22447136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of Zinc Transporter 8 Autoantibody in the Diagnosis of Type 1 Diabetes in Latin Americans.
    Gomes KF; Semzezem C; Batista R; Fukui RT; Santos AS; Correia MR; Passos-Bueno MR; Silva ME
    Sci Rep; 2017 Mar; 7(1):207. PubMed ID: 28303020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus.
    Yi B; Huang G; Zhou ZG
    Chin Med J (Engl); 2015 Sep; 128(17):2387-94. PubMed ID: 26315089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel autoantibodies to the β-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
    Gu Y; Merriman C; Guo Z; Jia X; Wenzlau J; Li H; Li H; Rewers M; Yu L; Fu D
    J Autoimmun; 2021 Aug; 122():102677. PubMed ID: 34130115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
    Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
    J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
    Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.
    Wenzlau JM; Liu Y; Yu L; Moua O; Fowler KT; Rangasamy S; Walters J; Eisenbarth GS; Davidson HW; Hutton JC
    Diabetes; 2008 Oct; 57(10):2693-7. PubMed ID: 18591387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study.
    Delli AJ; Vaziri-Sani F; Lindblad B; Elding-Larsson H; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Örtqvist E; Groop L; Bondinas GP; Papadopoulos GK; Lernmark Å;
    Diabetes; 2012 Oct; 61(10):2556-64. PubMed ID: 22787139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral responses to islet antigen-2 and zinc transporter 8 are attenuated in patients carrying HLA-A*24 alleles at the onset of type 1 diabetes.
    Long AE; Gillespie KM; Aitken RJ; Goode JC; Bingley PJ; Williams AJ
    Diabetes; 2013 Jun; 62(6):2067-71. PubMed ID: 23396399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.